What's new in regenerative medicine: Split up of the mesenchymal stem cell family promises new hope for cardiovascular repair

Rosa Vono, Gaia Spinetti, Miriam Gubernator, Paolo Madeddu

Research output: Contribution to journalArticlepeer-review

Abstract

Coronary artery disease (CAD) is exceedingly prevalent and requires care optimization. Regenerative medicine holds promise to improve the clinical outcome of CAD patients. Current approach consists in subsidizing the infarcted heart with boluses of autologous stem cells from the bone marrow. Moreover, mesenchymal stem cells (MSCs) are in the focus of intense research owing to an apparent superiority in plasticity and regenerative capacity compared with hematopoietic stem cells. In this review, we report recent findings indicating the presence, within the heterogeneous MSC population, of perivascular stem cells expressing typical pericyte markers. Moreover, we focus on recent research showing the presence of similar cells in the adventitia of large vessels. These discoveries were fundamental to shape a roadmap toward clinical application in patients with myocardial ischemia. Adventitial stem cells are ideal candidates for promotion of cardiac repair owing to their ease of accessibility and expandability and potent vasculogenic activity.

Original languageEnglish
Pages (from-to)689-699
Number of pages11
JournalJournal of Cardiovascular Translational Research
Volume5
Issue number5
DOIs
Publication statusPublished - Oct 2012

Keywords

  • Coronary artery disease
  • Mesenchymal stem cells
  • Pericytes
  • Regenerative medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics
  • Genetics(clinical)
  • Molecular Medicine
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'What's new in regenerative medicine: Split up of the mesenchymal stem cell family promises new hope for cardiovascular repair'. Together they form a unique fingerprint.

Cite this